16 Sep 2025 | 3 Mins Read
Zydus Lifesciences gains as canine drug gets USFDA approval
Flipitmoney
Zydus Lifesciences' wholly owned subsidiary ZyVet Animal Health launched the first FDA-approved generic treatment for canine urinary incontinence, phenylpropanolamine hydrochloride tablets, in the US. This marks a significant entry into the animal generics market, aiming to provide cost-effective symptom relief for dogs.